HealthInvest Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1M | Buy |
88,392
+12,511
| +16% | +$1.57M | 4.75% | 4 |
|
|
2025
Q1 | $8.39M | Buy |
75,881
+8,118
| +12% | +$898K | 3.71% | 11 |
|
|
2024
Q4 | $9.29M | Buy |
67,763
+7,156
| +12% | +$981K | 4.41% | 8 |
|
|
2024
Q3 | $6.98M | Buy |
60,607
+36,977
| +156% | +$4.26M | 3.28% | 12 |
|
|
2024
Q2 | $3.25M | Sell |
23,630
-19,850
| -46% | -$2.73M | 1.98% | 14 |
|
|
2024
Q1 | $6M | Buy |
43,480
+30,863
| +245% | +$4.26M | 3.65% | 5 |
|
|
2023
Q4 | $1.66M | Buy |
+12,617
| New | +$1.66M | 1.3% | 22 |
|
|
2022
Q4 | $22.2K | Buy |
+186
| New | +$22.2K | 0.04% | 29 |
|